The Coming of Age Story of RNAi Technology
The first RNA interference therapy was approved in 2018, after 20 years in development. What…
02/06/2021 - 6 minutes
Silence Therapeutics
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B
AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and…
26/03/2020 - 3 minutes
Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M
The UK-based biotech Silence Therapeutics has signed a deal worth up to €553M ($693M) with…
19/07/2019 - 2 minutes
UK Biotech Settles Lawsuit on the First RNAi Drug
Silence Therapeutics and Alnylam have reached a settlement that puts an end to a legal…
11/12/2018 - 3 minutes
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
Although biotech may seem like an industry that has only just gotten started, it was…
23/01/2018 - 10 minutes
RNA as a Therapy: Reviewing the Future Generation of Therapeutics
You’ve certainly heard about antibodies, peptides and even DNA as therapeutics, but what about RNA?…
19/09/2017 - 9 minutes
CRISPR meets RNAi: a whole new Targeted Therapy
Silence Therapeutics just announced preclinical data for a novel CRISPR therapy targeted to the liver using…
15/11/2016 - 2 minutes
